Meanwhile, Wang and Tong [130] found that oral administration of resveratrol increased monocyte SIRT1 levels, increased insulin sensitivity, and decreased blood glucose in patients with type 2 diabetes mellitus complicated with coronary heart disease. This evidence concerns the gene SIRT1 and type 2 diabetes mellitus.